

ANSTO LifeSciences is organised into five main groups, covering our main capabilities, facilities and research areas.
The Radiopharmaceutical Research and Development group is chaired by Dr Ivan Greguric and focuses on research and development in synthetic chemistry, radiochemistry, and radiotracer characterisation and pharmacology.
The Radionuclide Development group is chaired by Dr Ron Weiner and focuses on research and development of radionuclides.
The Integrative Biology group is chaired by Professor Richard Banati.
The Imaging group is chaired by Dr Marie-Claude Gregoire and focuses on pre-clinical exploration, and radiotracer characterisation and pharmacology.
This group is chaired by Dr Ron Weiner.